, operator of Open, Linked and Transparent economic marketplaces, today announced that Abattis Bioceuticals Corp. Abattis starts trading today on OTCQX beneath the symbol ‘ATTBF.’ U.S. Investors can find current economic disclosures and Real-Time Level 2 rates for the company on ‘We welcome Abattis to the OTCQX marketplace,’ said R. Cromwell Coulson, CEO and President of OTC Marketplaces Group. ‘Abattis joins an evergrowing group of Canadian exchange-listed companies that have selected to trade on the OTCQX market to provide its investors with transparent trading and easy access to its information and financials. We want the business continued success.’ Related StoriesRebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infectionAmgen's IMLYGIC receives positive opinion from CHMP for treatment of melanomaUniversity of Leicester awarded BBSRC grant to explore 3 key areas that influence human health’Abattis Bioceuticals is dedicated to providing a high degree of transparency to shareholders,’ said Abattis Bioceuticals Corp.See your doctor regularlyMost of us tend to assume that people should visit our eyes doctor when something is actually not right with this eyes. The simple truth is we ought to regularly visit our eye doctors. The eye exams might help spot some silent eye diseases, such as glaucoma, before they cause irreversible vision and damage loss. Remember:Many eye diseases could be treated with medicines; however, for some diseases, your doctor might recommend a surgical eye treatment treatment in India. It is to be mentioned that surgical eye caution treatment in India has turned into a common choice for many. Most medical procedure including cataract surgery have very high success rates.